Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis

Journal of the Neurological Sciences

Volumn 189, Issue 1-2, 2001, Pages 59-64

  Suzuki, S ^a   Kuwana, M ^a   Yasuoka, H ^a   Tanaka, K ^a   Fukuuchi, Y ^a   Kawakami, Y ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Acetylcholine receptor; Autoimmune disease; HLA; Immunogenetics; Myasthenia gravis; Thymectomy

Indexed keywords

CHOLINERGIC RECEPTOR; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; THYMECTOMY;

ADULT; AGE OF ONSET; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; JAPAN; MALE; MYASTHENIA GRAVIS; THYROIDITIS, AUTOIMMUNE;

EID: 0035881898     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00560-3     Document Type: Article

References (28)

1. Myasthenia gravis: immunological mechanisms and immunotherapy
2. Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases
3. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis
4. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis
5. A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C
6. HLA antigens in Japanese patients with myasthenia gravis
7. Myasthenia gravis
8. Identification of a novel HLA class II association with DQB1*0502 in an Italian myasthenic population
9. Myasthenia gravis: recommendations for clinical research standards
10. PCR-RFLP
11. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups
12. Myasthenia gravis: occurrence, failure in euromuscular transmission, clinical implementation of anti-AchR antibodies, and therapeutic progress
13. Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis
14. Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types
15. Myasthenia gravis in Hong Kong Chinese: 1. Epidemiology and adult disease
16. Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese
17. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan
18. HLA-DPB1 allele associates with early-onset myasthenia gravis in Japan
19. Combinations of HLA-DPB1 and HLA-DQB1 alleles determine susceptibility to early-onset myasthenia gravis in Japan
20. Human acetylcholine receptor presentation in myasthenia gravis: DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules
21. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor
22. HLA type is not indicative for the effect of thymectomy in myasthenia gravis
23. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations
24. Correlation of thymic pathology with HLA in myasthenia gravis
25. The impact of HLA on long-term outcome after thymectomy for myasthenia gravis
26. Involvement of HLA in clinical courses of myasthenia gravis
27. Factors influencing the clinical type and course of myasthenia gravis
28. HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis